How do you know if you are losing muscle instead of fat on a GLP-1?
Key takeaways
Dr. Linda's take
This is one of the fears I hear most often, usually phrased as some version of "how do I know the weight coming off is the weight I actually want gone?" It is a good question, and it deserves a real answer rather than reassurance.
Here is the honest shape of it. Yes, when you lose weight by any method, a portion of what you lose is lean mass. No, you cannot fully tell fat from muscle by looking in the mirror or reading the scale, because the scale only knows total pounds and says nothing about what those pounds were made of. What you can do is pay attention to function and, if you want a real number, use a body-composition scan. And most of what shapes the answer is within your control: how much protein you eat, and whether you keep asking your muscles to work while your body gets smaller.
Do you lose muscle as well as fat on a GLP-1?
Start with what the scans actually show. In the tirzepatide SURMOUNT-1 body-composition substudy, participants underwent dual-energy X-ray absorptiometry (DXA) scans, and of the weight they lost about 75% was fat mass and 25% was lean mass, essentially the same split for tirzepatide and for placebo. Read that last part twice: the people losing weight without the drug lost lean mass in the same proportion as the people on it, which tells you this is a feature of losing weight, not something the medication piles on top.
The wider picture agrees. A 2026 meta-analysis of 20 randomized trials, covering 15,782 participants, found that lean mass made up 25% to 39% of the total weight lost on incretin medications: 35.2% with semaglutide, 25.4% with tirzepatide, and 26.8% with liraglutide. So a fraction of the weight is lean mass, and it is real, but it is not the whole story.
The part that reframes the worry is what "lean mass" means. A pooled analysis put lean mass loss at roughly 25% of the total weight lost on GLP-1 receptor agonists, and found that relative lean mass, meaning lean mass as a percentage of total body weight, was unaffected. Lean mass on a scan is a mixed bag: it includes body water, organ tissue, and connective tissue, not just muscle. So when the number drops, some of that is fluid and other tissue shifting with a smaller body. You became a smaller person who was still made up of roughly the same share of lean tissue. If you want the fuller breakdown, we cover it in how much muscle you lose and whether you can get it back.
How can you tell if you are losing muscle instead of fat?
There are two honest ways to answer this, and they work best together: plain-language signs you can feel, and objective measures that put a number on it.
The signs you can watch are about function, not appearance. Muscle is what lets you climb stairs without your legs burning, carry groceries in from the car, stand up from a low chair, and open a stubborn jar. If those everyday tasks are steadily getting harder, if you feel weaker or wobblier on your feet, or if your energy and stamina are dropping in a way that food and sleep do not explain, those are worth taking seriously as possible signs that too much of what you are losing is lean tissue. Strength that holds steady or improves, by contrast, is one of the most reassuring signals that your loss is skewing toward fat.
The objective measures put an actual number on the fat-versus-lean split. A DXA scan is the tool most of the trials used, including the substudy above, and it separates your body into fat mass, lean mass, and bone. A bioimpedance scan, the kind found in many gyms, clinics, and some home scales, estimates the same split by sending a small electrical current through the body; it is more convenient and less precise than DXA, and it drifts with how hydrated you are, so it is most useful for tracking your own trend over time rather than as a single verdict. The key idea with any of these is the trend: one reading tells you little, but the same scan repeated over months shows whether the pounds leaving are mostly fat or whether lean mass is dropping faster than you would like. A tape measure and how your strength is trending are humble but real stand-ins if a scan is not available.
None of these is something to interpret alone or panic over from a single number. They are inputs a clinician can help you weigh against your goals.
What protects muscle while you lose weight?
This is the part where your effort genuinely changes the outcome, and two levers have the strongest evidence.
Resistance training is the first. Supervised resistance exercise lasting more than 10 weeks can produce large gains in lean mass, on the order of 3 kg, and about a 25% increase in strength in men and women, which is why the authors of a Diabetes Care review proposed that tailored resistance training be recommended as an adjunct to incretin therapy. It is also the single best thing you can do to keep the function that everyday signs are measuring. Adding structured exercise to weight loss preserved nearly half of the fat-free mass that would otherwise have been lost. We compare the two levers head to head in does strength training protect muscle better than protein alone.
Protein is the second. During weight loss specifically, a higher-protein diet mitigated the loss of fat-free mass by about 0.43 kg compared with a standard-protein diet. And when paired with resistance training across 49 studies, protein supplementation increased fat-free mass gains by about 0.30 kg, with no further benefit once total intake passed roughly 1.62 g per kilogram per day. Appetite often drops sharply while you are losing weight, which makes hitting a protein target harder and more deliberate; how much protein do you need to protect muscle walks through the specific number to aim for. For women navigating the menopause transition at the same time, whether muscle loss runs deeper in perimenopause looks at the added wrinkle of shifting hormones.
If you are trying to figure out whether any of this fits your situation, our eligibility quiz is a place to begin.
Frequently asked questions
Can the bathroom scale tell me if I am losing muscle or fat?
No. A standard scale only measures total body weight, so it cannot distinguish a pound of fat from a pound of lean tissue. To see the split you need either functional signs, like whether your strength and everyday tasks are holding up, or a body-composition measure. In the tirzepatide SURMOUNT-1 body-composition substudy, participants underwent dual-energy X-ray absorptiometry (DXA) scans, and of the weight they lost about 75% was fat mass and 25% was lean mass, essentially the same split for tirzepatide and for placebo.
What is the most accurate way to measure fat versus muscle loss?
A DXA scan is the tool most weight-loss trials rely on, because it separates the body into fat, lean mass, and bone. Bioimpedance scans are more accessible but less precise and shift with hydration, so they are best for tracking your own trend rather than a one-time verdict. Either way, repeated measures over months tell you far more than any single reading.
Does losing lean mass on a scan mean I am losing muscle?
Not necessarily. Lean mass includes body water, organ tissue, and connective tissue, not only muscle, so part of the drop is fluid and other tissue shifting with a smaller body. A pooled analysis put lean mass loss at roughly 25% of the total weight lost on GLP-1 receptor agonists, and found that relative lean mass, meaning lean mass as a percentage of total body weight, was unaffected.
How much of the weight lost is usually lean mass?
A 2026 meta-analysis of 20 randomized trials, covering 15,782 participants, found that lean mass made up 25% to 39% of the total weight lost on incretin medications: 35.2% with semaglutide, 25.4% with tirzepatide, and 26.8% with liraglutide. The rest was fat, and lean mass is not the same as muscle because it also includes water and organ tissue.
What can I do to lose more fat and less muscle?
The two best-supported levers are resistance training and adequate protein. Supervised resistance exercise lasting more than 10 weeks can produce large gains in lean mass, on the order of 3 kg, and about a 25% increase in strength in men and women, which is why the authors of a Diabetes Care review proposed that tailored resistance training be recommended as an adjunct to incretin therapy. During weight loss, a higher-protein diet mitigated the loss of fat-free mass by about 0.43 kg compared with a standard-protein diet.
References
1. Diabetes, obesity & metabolism (2025). Body composition changes during weight reduction with tirzepatide in the SURMOUNT-1 study of adults with obesity or overweight. PubMed PMID 39996356. https://pubmed.ncbi.nlm.nih.gov/39996356/ (Accessed 2026-07-22).
2. Diabetes, obesity & metabolism (2026). Lean Mass Changes With Incretin Therapy Versus Lifestyle Intervention: A Systematic Review and Meta-Analysis of Randomised Controlled Trials. PubMed PMID 41877354. https://pubmed.ncbi.nlm.nih.gov/41877354/ (Accessed 2026-07-22).
3. Metabolism: clinical and experimental (2025). Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition: Systematic review and network meta-analysis. PubMed PMID 39719170. https://pubmed.ncbi.nlm.nih.gov/39719170/ (Accessed 2026-07-22).
4. Diabetes care (2024). Incretin-Based Weight Loss Pharmacotherapy: Can Resistance Exercise Optimize Changes in Body Composition?. PubMed PMID 38687506. https://pubmed.ncbi.nlm.nih.gov/38687506/ (Accessed 2026-07-22).
5. The American journal of clinical nutrition (2012). Effects of energy-restricted high-protein, low-fat compared with standard-protein, low-fat diets: a meta-analysis of randomized controlled trials. PubMed PMID 23097268. https://pubmed.ncbi.nlm.nih.gov/23097268/ (Accessed 2026-07-22).
6. British journal of sports medicine (2018). A systematic review, meta-analysis and meta-regression of the effect of protein supplementation on resistance training-induced gains in muscle mass and strength in healthy adults. PubMed PMID 28698222. https://pubmed.ncbi.nlm.nih.gov/28698222/ (Accessed 2026-07-22).
7. Diabetes, obesity & metabolism (2026). Effects of Calorie Restriction With and Without Strength, Endurance or Mixed Training on Fat-Free and Skeletal Muscle Mass in Overweight or Obese Individuals-A Systematic Review With Pairwise Meta-Analysis and Network Meta-Analysis of Randomized Controlled Studies. PubMed PMID 42144246. https://pubmed.ncbi.nlm.nih.gov/42144246/ (Accessed 2026-07-22).
---
*This article is general education and is not medical advice. It cannot tell you what is right for your body. Talk with a licensed clinician about your own situation.*
*Written and clinically reviewed by Dr. Linda Moleon, MD. Last reviewed 2026-07-22.*
Keep reading

Do Black and Latina women report different GLP-1 side effects?
The GLP-1 side-effect profile looks broadly similar across groups, but the trials under-enrolled Black and Latina women. Dr. Linda gives the honest answer and what the one race-stratified analysis found.

Is a GLP-1 safe to start during perimenopause?
Perimenopause is not a contraindication Ā· eligibility is set by weight, not life stage. Dr. Linda walks through the real contraindications and the muscle, bone, gut, and pregnancy points that matter most in midlife.

How does a GLP-1 affect insulin resistance in PCOS?
Insulin resistance is a core driver of PCOS. Dr. Linda explains how GLP-1 medicines improve it, what the meta-analyses actually found, and why the effect is not guaranteed for everyone.

Is retatrutide available in Miami yet?
Retatrutide is still in clinical trials and not FDA approved, so no clinic in Miami can prescribe it yet. Dr. Linda explains what the early data shows and which approved options you can actually start now.

What is the lowest GLP-1 dose that still holds your weight?
The smallest maintenance dose that still holds a result has never been established in a trial Ā· the studies compared a full dose against stopping. Dr. Linda explains what the evidence and labels actually show.

Is there a link between menopause insomnia and weight loss on a GLP-1?
Sleep and weight regulation are genuinely intertwined in midlife, and menopause makes sleep harder in measurable ways. Dr. Linda separates what the evidence shows on apnea from the unproven insomnia claim.
